SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-332655"
 

Sökning: id:"swepub:oai:DiVA.org:uu-332655" > Real-world costs of...

Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

Eriksson, Daniel (författare)
Quantify Res, Hantverkargatan 8, S-11221 Stockholm, Sweden.
Karlsson, Linda (författare)
Quantify Res, Hantverkargatan 8, S-11221 Stockholm, Sweden.
Eklund, Oskar (författare)
Quantify Res, Hantverkargatan 8, S-11221 Stockholm, Sweden.
visa fler...
Dieperink, Hans (författare)
Odense Univ Hosp, Dept Nephrol, Sdr Blvd 29, DK-5000 Odense C, Denmark.
Honkanen, Eero (författare)
Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Haartmaninkatu 4,POB 372, FIN-00029 Hus Helsinki, Finland.
Melin, Jan (författare)
Uppsala universitet,Njurmedicin
Selvig, Kristian (författare)
Vestre Viken Hosp Trust, Dept Nephrol, Postboks 800 3004, Drammen, Norway.
Lundberg, Johan (författare)
Otsuka Pharma Scandinavia, Birger Jarlsgatan 27, S-11145 Stockholm, Sweden.
visa färre...
Quantify Res, Hantverkargatan 8, S-11221 Stockholm, Sweden Odense Univ Hosp, Dept Nephrol, Sdr Blvd 29, DK-5000 Odense C, Denmark. (creator_code:org_t)
2017-08-15
2017
Engelska.
Ingår i: BMC Health Services Research. - : Springer Science and Business Media LLC. - 1472-6963. ; 17
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: There is limited real-world data on the economic burden of patients with autosomal dominant polycystic kidney disease (ADPKD). The objective of this study was to estimate the annual direct and indirect costs of patients with ADPKD by severity of the disease: chronic kidney disease (CKD) stages 1-3; CKD stages 4-5; transplant recipients; and maintenance dialysis patients. Methods: A retrospective study of ADPKD patients was undertaken April-December 2014 in Denmark, Finland, Norway and Sweden. Data on medical resource utilisation were extracted from medical charts and patients were asked to complete a self-administered questionnaire. Results: A total of 266 patients were contacted, 243 (91%) of whom provided consent to participate in the study. Results showed that the economic burden of ADPKD was substantial at all levels of the disease. Lost wages due to reduced productivity were large in absolute terms across all disease strata. Mean total annual costs were highest in dialysis patients, driven by maintenance dialysis care, while the use of immunosuppressants was the main cost component for transplant care. Costs were twice as high in patients with CKD stages 4-5 compared to CKD stages 1-3. Conclusions: Costs associated with ADPKD are significant and the progression of the disease is associated with an increased frequency and intensity of medical resource utilisation. Interventions that can slow the progression of the disease have the potential to lead to substantial reductions in costs for the treatment of ADPKD.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)

Nyckelord

Polycystic kidney diseases
ADPKD
Health Care Costs
Health Expenditures
Cost of Illness

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy